Relation between sequence and structure of HIV-1 protease inhibitor complexes: A model system for the analysis of protein Flexibility

Journal of Molecular Biology

Volumn 315, Issue 1, 2002, Pages 21-52

  Zoete, V ^a   Michielin, O ^a   Karplus, M ^a,b  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b HARVARD UNIVERSITY   (United States)

Author keywords

Correlated motions; HIV 1 protease; Molecular dynamics; Normal mode analysis; Structural changes

Indexed keywords

LIGAND; PROTEINASE;

AMINO ACID SEQUENCE; ANALYTIC METHOD; ARTICLE; BIOLOGICAL MODEL; CORRELATION ANALYSIS; DATA BASE; ENERGY; ENZYME ANALYSIS; ENZYME STRUCTURE; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR DYNAMICS; MUTATION; PRIORITY JOURNAL; PROTEIN INTERACTION; SAMPLING; SEQUENCE ANALYSIS; X RAY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0036298514     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.2001.5173     Document Type: Article

References (70)

1. Molecular dynamics simulations in biology
2. Study of protein dynamics by X-ray diffraction
3. 15N NMR relaxation measurements for main-chain and side-chain nuclei of hen egg white lysozyme
4. 15N NMR relaxation measurements of hen egg white lysozyme denatured in trifluoroethanol
5. Multiple conformational states of proteins: A molecular dynamics analysis of myoglobin
6. Dynamics of ligand binding to myoglobin
7. How different amino acid sequences determine similar protein structures: The structure and evolutionary dynamics of the globins
8. New database
9. Structural biology of HIV
10. Active human immunodeficiency virus protease is required for viral infectivity
11. Inhibitors of HIV-1 protease: A major success of structure-assisted drug-design
12. Three-dimensional structure of aspartyl protease from human immunodeficiency virus HIV-1
13. Conserved folding in retroviral proteases: Crystal structure of a synthetic HIV-1 protease
14. 2 symmetry-based diol inhibitors of HIV-1 protease
15. Database of three-dimensional structures of HIV proteinase
16. Database of HIV proteinase structures
17. Ligplot: A program to generate schematic diagrams of protein-ligand interactions
18. Complete mutagenesis of the HIV-1 protease
19. In vitro selection and characterization of human immunodeficiency virus type 1 (HIV-1) isolates with reduced sensitivity to hydroxyethylamino sulfonamide inhibitors of HIV-1 aspartyl protease
20. In vitro selection and characterization of VX-478 resistant HIV-1 variants
21. Selection of multiple human immunodeficiency virus type 1 variants that encode viral proteases with decreased sensitivity to an inhibitor of the viral protease
22. Phenotypic and genotypic analysis of clinical HIV-1 isolates reveals extensive protease inhibitor cross-resistance: A survey of over 6000 samples
23. Comparison of conformational characteristics in structurally similar protein pairs
24. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease
25. Structure-based thermodynamic analysis of HIV-1 protease inhibitors
26. Rapid X-ray diffraction analysis of HIV-1 protease-inhibitor complexes: Inhibitor exchange in single crystals of the bound enzyme
27. Crystal structure at 1.9-à resolution of human immunodeficiency virus (HIV) ii protease complexed with L-735,524, an orally bioavailable inhibitor of the HIV proteases
28. Flexibility and function in HIV protease: Dynamics of the HIV-1 protease bound to the asymmetric inhibitor kynostatin 272 (KNI-272)
29. Dynamic flexibility of protein-inhibitor complexes: A study of the HIV-1 protease/KNI-272 complex
30. Structure of HIV-1 protease with KNI-272, a tight-binding transition-state analog containing allophenylnorstatine
31. Harmonic analysis of large systems. I. Methodology
32. Domain communication in the dynamical structure of human immunodeficiency virus 1 protease
33. Molecular dynamics of HIV-1 protease
34. Structural stability of binding sites: Consequences for binding affinity and allosteric effects
35. Dynamics of folded proteins
36. Temperature-dependent X-ray diffraction as a probe of protein structural dynamics
37. Crystallographic studies of the dynamic properties of lysozyme
38. Internal mobility of ferrocytochrome c
39. Multiple copy simultaneous search and construction of ligands in binding sites: Application to inhibitors of HIV-1 aspartic proteinase
40. Human immunodeficiency virus. Mutations in the viral protease that confer resistance to saquinavir increase the dissociation rate constant of the protease-saquinavir complex
41. Domain flexibility in retroviral proteases: Structural implications for drug resistant mutations
42. Crystal structure of an in vivo HIV-1 protease mutant in complex with saquinavir: Insights into the mechanisms of drug resistance
43. X-ray crystallographic studies of a series of penicillin-derived asymetric inhibitors of HIV-1 protease
44. Cyclic HIV-1 protease inhibitors derived from mannitol: Synthesis, inhibitory potencies, and computational predictions of binding affinities
45. MOLMOL: A program for display and analysis of macromolecular structures
46. Hydrophilic peptides derived from the transframe region of gag-pol inhibit the HIV-1 protease
47. General atomic and molecular electronic structure system
48. Potential derived charges using a geodesic point selection scheme
49. All-atom empirical potential for molecular modeling and dynamics studies of proteins
50. CHARMM: A program for macromolecular energy, minimization and dynamics calculations
51. Mechanism for the destabilization of the dimer interface in a mutant HIV-1 protease: A molecular dynamics study
52. Structure of HIV-1 protease with KNI-272: A transition state mimetic inhibitor containing allophenylnorstatine
53. Solution NMR evidence that the HIV-1 protease catalytic aspartyl groups have different ionization states in the complex formed with the asymmetric drug KNI-272
54. Analysis of the structure of HIV-1 protease complexed with a hexapeptide inhibitor. Part II: Molecular dynamic studies of the active site region
55. Calculation of relative binding free energies of peptidic inhibitors to HIV-1 protease and its I84V mutant
56. Comment on a "fluctuation and cross correlation analysis of protein motions observed in nanosecond molecular dynamics simulations"
57. The contribution of vibrational entropy to molecular association
58. Ligand-induced conformational changes in ras p21: A normal mode and energy minimization analysis
59. Inhibition and catalytic mechanism of HIV-1 aspartic protease
60. Viracept (nelfinavir mesylate, AG1343): A potent, orally bioavailable inhibitor of HIV-1 protease
61. Comparative analysis of the X-ray structures of HIV-1 and HIV-2 proteases in complex with CGP 53820, a novel pseudosymmetric inhibitor
62. A check on rational drug design: Crystal structure of a complex of human immunodeficiency virus type 1 protease with a novel gamma-turn mimetic inhibitor
63. 2symmetric phosphinate. Synthesis and crystallographic analysis
64. Rational design, synthesis, and crystallographic analysis of a hydroxyethylene-based HIV-1 protease inhibitor containing a heterocyclic P1′-P2′ amide bond isostere
65. Structure-based design of novel HIV protease inhibitors: Carboxamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent nonpeptidic inhibitors
66. Crystal structures of complexes of a peptidic inhibitor with wild-type and two mutant HIV-1 proteases
67. Crystal structure of HIV-1 protease in complex with a potent and orally bioavailable inhibitor of the enzyme